Back
NF1HGNC Autosomal dominantPubMed⭐ À la unePenetrance update

Transmission ratio distortion of NF1 mutant alleles in familial Neurofibromatosis type 1.

Pei Y, Browne A, Creus-Bachiller E, et al.Genet Med 2026 · August 2026
Relevance score
9/10
Disease / domain
Neurofibromatosis type 1
Source
PubMed
PMID 42583752
Share on LinkedInBluesky

Gene / mechanism

Transmission ratio distortion of the mutant NF1 allele, attributed by the authors to clonal selection of NF1-null cells within the early embryonic germline.

Summary

Neurofibromatosis type 1 (about 1:3,000) is classically assumed to follow strict Mendelian transmission. The authors analysed transmission patterns in 322 NF1 families from four well-characterised cohorts, using strict inclusion criteria to minimise ascertainment bias and exclude possible mosaic cases. Among 701 offspring, 61.1% were diagnosed with NF1, significantly exceeding the expected 50% (p = 5 × 10-9), with the excess present for both female (62.8%) and male (58.5%) transmitters. Sub-sampling and large-scale random down-sampling analyses ruled out cohort size and other confounders as an explanation. The authors propose clonal selection of NF1-null cells within the early embryonic germline, with implications for genetic counselling and prenatal diagnosis.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

If confirmed, this shifts the recurrence figure taken for granted in autosomal dominant transmission: about 61% rather than 50% for an affected parent, which is not trivial when weighing prenatal diagnosis or preimplantation testing. Caution remains warranted, as these are families recruited in expert centres and mosaicism exclusion rests on clinical and molecular criteria, two sources of residual bias that are hard to eliminate entirely. The germline selection hypothesis is attractive and consistent with NF1 tumour biology, but here it remains an interpretation without direct functional demonstration: I would treat it as an explanatory lead, not an established fact.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 3/3Novelty 2/2Sample 1/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 3/3 · Novelty: 2/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 9/10

Keywords

neurofibromatosisgenetic counsellingtransmission ratio distortionprenatalrecurrence risk

More articles on NF1

Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime